Sinovac Biotech Ltd
F:SVQ

Watchlist Manager
Sinovac Biotech Ltd Logo
Sinovac Biotech Ltd
F:SVQ
Watchlist
Price: 5.58 EUR Market Closed
Market Cap: 556m EUR

Operating Margin
Sinovac Biotech Ltd

-84.3%
Current
-47%
Average
-4.1%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-84.3%
=
Operating Profit
-362m
/
Revenue
429.2m

Operating Margin Across Competitors

No Stocks Found

Sinovac Biotech Ltd
Glance View

Market Cap
556m EUR
Industry
Biotechnology

Sinovac Biotech Ltd. is a holding company, which engages in the research, development, manufacture, and commercialization of vaccines that protect against human infectious diseases. The company is headquartered in Beijing, Beijing and currently employs 1,959 full-time employees. The company went IPO on 2009-11-13. The firm is a biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases, including hepatitis A, hepatitis B, seasonal influenza, Haemagglutinase5 Neuraminidase1 (H5N1) and Influenza A (H1N1) pandemic influenza and mumps. The firm's pipeline consists of vaccine candidates in the clinical and pre-clinical development Phases in China. The firm is engaged in the sales, marketing, manufacturing and development of vaccines for infectious disease. The firm develops various products, including Healive, Bilive, Anflu, Panflu Whole Viron Pandemic Influenza Vaccine, Split Viron Pandemic Influenza Vaccine, Panflu.1, RabEnd, Mumps Vaccine, Enterovirus 71 (EV71) Vaccine, Pneumococcal Polysaccharide Vaccine, Pneumococcal Conjugate Vaccine, Rubella Vaccine, Varicella Vaccine and Sabin Inactivated Polio Vaccine.

SVQ Intrinsic Value
46.59 EUR
Undervaluation 88%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-84.3%
=
Operating Profit
-362m
/
Revenue
429.2m
What is the Operating Margin of Sinovac Biotech Ltd?

Based on Sinovac Biotech Ltd's most recent financial statements, the company has Operating Margin of -84.3%.

Back to Top